UPDATE 1-FDA panel to discuss Roche arthritis drug July 29 - Reuters
 US Recall News (press release) |
UPDATE 1-FDA panel to discuss Roche arthritis drug July 29
Reuters - 2 hours ago LONDON, June 5 (Reuters) - Roche Holding AG's (ROG.VX: Quote, Profile, Research) experimental arthritis drug Actemra will be considered for approval by a US Food and Drug Administration panel on July 29. Drug companies drain scientific brains from FDA USA Today FDA sends Steris a warning letter about sterilizer The Plain Dealer - cleveland.com US Recall News (press release) - Baltimore Sun - Common Dreams (press release) - Medical News Today (press release) all 41 news articles |
